Form 4: Arteris Inc. CEO Charles Janac Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Arteris, Inc. CEO Charles Janac sold 1,973 shares of common stock at $8.19 per share on March 5, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 5, 2025, Charles Janac, the President and CEO of Arteris, Inc., sold 1,973 shares of Arteris common stock at a price of $8.19 per share.
- The transaction was executed under a pre-arranged 10b5-1 trading plan adopted on February 27, 2024.
- Following the transaction, Janac directly owns 325,267 shares of Arteris common stock.
- Janac also indirectly owns 9,907,691 shares through Bayview Legacy, LLC, where he serves as manager, and 56,252 shares through the Charles and Lydia Janac Trust, where he serves as trustee.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.
Stakeholder Impact
- The stock sale by the CEO could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date the 10b5-1 trading plan was adopted by the Reporting Person |
| 03/05/2025 | Date of the transaction (stock sale) |
| 03/07/2025 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.